Status:
RECRUITING
Bioimpedance Analysis for Hemodialysis
Lead Sponsor:
Cishan Hospital, Ministry of Health and Welfare
Conditions:
Hemodialysis Complication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if bioimpedance-guided fluid management can help decrease hemodialysis complications. The main questions it aims to answer are: Does bioimpedance-guided fl...
Detailed Description
The goal of this clinical trial is to learn if bioimpedance-guided fluid management can decrease major adverse cardiovascular events (MACE), symptoms during hemodialysis, or other important outcomes s...
Eligibility Criteria
Inclusion
- Has received hemodialysis \>= 3 months
- Has at least 1 pair of intact same-side upper extremity and lower extremity
Exclusion
- Pregnant
- With a cardiac pacemaker
- With metallic implants that may interfere with measurements (cardiac stents acceptable)
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06573567
Start Date
September 1 2024
End Date
April 30 2026
Last Update
January 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cishan Hospital, MOHW, Taiwan
Kaohsiung City, Taiwan, 842